We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

6 Sep 2018 07:00

RNS Number : 9054Z
DeepMatter Group PLC
06 September 2018
 

6 September 2018

DeepMatter Group Plc

("DeepMatter", the "Group" or the "Company")

 

Interim results for the six months ended 30 June 2018

 

DeepMatter (AIM: DMTR), the AIM quoted company focusing on digitizing chemistry, announces its unaudited interim results for the six months ended 30 June 2018.

 

Highlights:

· On track to deliver the Company's strategic roadmap to digitize chemistry

· Has now entered into agreements with five international organisations for its DigitalGlassware™ Pioneer Programme

· Loss after tax of £0.98 million (2017: loss £0.51 million)

· Cash and short-term deposits at 30 June 2018 of £2.07 million (31 December 2017: £3.27 million)

· Net assets at 30 June 2018 of £7.14 million (31 December 2017: £8.11 million)

· Post period end, Mark Warne appointed Chief Executive Officer on 3 July 2018

 

Mark Warne, Chief Executive Officer of DeepMatter, said:

"Our DigitalGlassware™ platform brings code, structure and order into the chemistry lab environment and enables recordable, shareable, reproduceable chemistry whilst also championing speed, simplicity and unhindered discovery.

 

The Group is progressing well with its DigitalGlassware™ Pioneer Programme and, moving forward, we keenly anticipate further deployments with key innovators. We remain focused on building credibility, awareness and understanding of the DigitalGlassware™ platform, before rolling out the platform to the broader community."

For further information:

DeepMatter Group plc

www.deepmatter.io

Mark Warne, Chief Executive Officer

T: 0141 548 8156

 

 

Stockdale Securities Limited

Tom Griffiths/Edward Thomas

 

T: 020 7601 6100

 

 

CHAIRMAN AND CHIEF EXECUTIVE'S JOINT STATEMENT

 

The year to date has seen important corporate and operational developments at DeepMatter as the Company has moved from a focus on R&D activity to its first corporate engagements. We are pleased to report that the Group remains on track in progressing its strategic roadmap to digitize chemistry.

 

In May 2018, to better represent its vision and strategy, the Company rebranded as DeepMatter, and concurrently launched a new website (www.deepmattergroup.io). This has been received well by the Group's stakeholders, commercial partners and the wider industry. The Group announced in June 2018 that Mark Warne would join the Company full time as Chief Executive Officer, while James Ede-Golightly, then a Non-Executive Director of the Company, would become Non-Executive Chairman on an interim basis whilst the search for a new Non-Executive Chairman was undertaken. This search is now in process and we anticipate making a further announcement on this appointment in due course.

 

The Group has steadily progressed adoption of its DigitalGlassware™ big data and analysis platform, which helps people involved across research and process development sectors to perform and work together, addressing the industry need for reproducibility in chemistry. The Company's vision is to ultimately enable an autonomous synthesis engine, the Chemputer™. DigitalGlassware™ comprises a powerful and easy-to-use software interface with a unique, low footprint sensor array, which collects, stores and processes data generated from chemical experiments and allows access to reproducible chemistry via internet protocols.

 

Shortly after the end of the period, the Group announced that it had entered into agreements with a total of five organisations for its DigitalGlassware™ Pioneer Programme (the "Pioneers"), representing the Company's minimum target for the whole of 2018. The Pioneers include two leading international life science reagent and chemicals manufacturers, a world-renowned US-headquartered research centre and two universities - one in the UK and one in North America. Entering into agreements with this range of target users reflects the Company's previously described plan to select a range of companies and institutions to trial its technology, allowing observation of technology performance in different operating environments and locations worldwide. The Group anticipates entering into further pioneer agreements during the remainder of this year.

 

Experiments and tests using DigitalGlassware™ as part of the Pioneer Programme are contributing towards context rich data content, capable of being interrogated with artificial intelligence and machine learning algorithms, helping to provide the chemistry community an understanding of how it can help to improve the outcomes of chemical processes, including precision and reproducibility, while also discovering/enabling new synthetic routes and chemical entities.

 

Scientific credibility of the Group's approach, ultimately an important factor in the Group's industry engagements, has been underpinned by relevant high-profile publications and Nature, Science and PNAS by the Group's Scientific Founder, Professor Lee Cronin FRSE FRSC, and the granting of patents assigned to the Group under its agreement with the University of Glasgow.

 

Financial Review

 

For the half year ended 30 June 2018, the Group incurred a loss before tax of £905,000 (2017: loss of £573,000) which less a tax credit of £98,000 (2017: tax credit £68,000) and coupled with a loss of £173,000 from discontinued operations of the Scanning Ion Conductance Microscope ("SICM") business (2017: loss from discontinued operations £nil), resulted in an overall loss after tax of £980,000 (2017: loss of £505,000).

 

The Group continues to benefit from a sound balance sheet with a cash balance at 30 June 2018 of £2.07 million (30 June 2017: £4.28 million) compared to £3.27 million at 31 December 2017. The £1.2 million decrease in cash during the half year is mainly attributable to the continuing operations of the Group, in particular research and development and overhead expenditure costs, together with funding SICM's losses ahead of our planned exit from this business.

 

Outlook 

 

Our DigitalGlassware™ platform brings code, structure and order into the chemistry lab environment and enables recordable, shareable, reproduceable chemistry whilst also championing speed, simplicity and unhindered discovery.

 

The Group is progressing well with its DigitalGlassware™ Pioneer Programme and, moving forward, we keenly anticipate further deployments with key innovators. We remain focused on building credibility, awareness and understanding of the DigitalGlassware™ platform, before rolling out the platform to the broader community.

 

 

 

James Ede-Golightly (Non-Executive Chairman) and Mark Warne (Chief Executive Officer)

 

6 September 2018

Company Number: 05845469

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE SIX MONTHS TO 30 JUNE 2018

 

 

6 months ended 30 June

 2018

6 months ended 30 June

 2017

Year ended 31 December 2017

 

(Unaudited)

(Unaudited)

(Audited)

 

£'000

£'000

£'000

 

 

 

 

 

 

 

 

Revenue

-

-

-

Research and development costs

(628)

(502)

(1,224)

Share based payments

(3)

-

(1)

Administrative costs

(280)

(82)

(356)

Operating loss

(911)

(584)

(1,581)

Finance income

6

11

22

Loss before tax

(905)

(573)

(1,559)

Income tax credit

98

68

137

Loss from continuing operations

(807)

(505)

(1,422)

 

 

 

 

Loss from discontinued operations

(173)

-

(42)

Loss and total comprehensive loss for the period

(980)

(505)

(1,464)

 

Loss per share attributable to the equity holders of the Company:

 

 

 

Basic and diluted loss per share (pence) on continuing operations

(0.15)

(0.10)

(0.27)

Basic and diluted loss per share (pence) on total operations

(0.18)

(0.10)

(0.28)

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2018

 

As at 30 June

As at 30 June

As at 31 December

 

2018

2017

2017

 

(Unaudited)

(Unaudited)

(Audited)

 

£'000

£'000

£'000

Assets

 

 

 

Non-current assets

 

 

 

Intangible assets and goodwill

4,938

4,213

4,958

Investments

3

3

3

Plant and equipment

32

29

31

 

4,973

4,245

4,992

Current assets

 

 

 

Inventories

27

-

10

Trade and other receivables

Taxation recoverable

149

98

66

68

127

-

Cash and cash equivalents

2,066

4,285

3,265

 

2,340

4,419

3,402

Liabilities

 

 

 

Current liabilities

 

 

 

Trade and other payables

 (177)

 (253)

 (281)

Net current assets

 2,163

 4,166

 3,121

 

Total net assets

7,136

8,411

8,113

Equity and liabilities

 

 

 

Shareholders' equity

 

 

 

Called up share capital

55

53

55

Share premium

3,287

3,287

3,287

Merger reserve

5,334

4,880

5,334

Shares to be issued reserve

204

-

204

Share based payments reserve

4

-

1

Retained (deficit) / earnings

(1,748)

191

(768)

Total equity attributable to shareholders of the Company

7,136

8,411

8,113

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE SIX MONTHS ENDED 30 JUNE 2018

 

 

Share equity

Share premium

Merger reserve

Share based payment reserve

Shares to be issued reserve

Retained earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 December 2016

53

3,287

4,880

-

-

696

8,916

Total comprehensive loss for the six months to 30 June 2017

 -

-

-

-

-

(505)

(505)

Balance at 30 June 2017

53

3,287

4,880

-

-

191

8,411

Total comprehensive loss for the six months to 31 December 2017

-

-

-

-

-

(959)

(959)

Transactions with owners

 

 

 

 

 

 

 

Shares to be issued and issuable on acquisition of subsidiary

2

-

454

-

204

-

660

Share based payment charge

-

-

-

1

-

-

1

Balance at 31 December 2017

55

3,287

5,334

1

204

(768)

8,113

Total comprehensive loss for the six months to 30 June 2018

-

-

-

-

-

(980)

(980)

Transactions with owners

 

 

 

 

 

 

 

Share based payment charge

-

-

-

3

-

-

3

Balance at 30 June 2018

55

3,287

5,334

4

204

(1,748)

7,136

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE SIX MONTHS ENDED 30 JUNE 2018

 

 

6 months ended 30 June

6 months ended 30 June

Year

 ended 31 December

 
 
 

 

2018

2017

2017

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

£'000

£'000

£'000

 

Cash flows from operating activities

 

 

 

 

Operating loss from continuing operations

(911)

(584)

(1,581)

 

Loss from discontinued operations

(173)

-

(42)

 

Adjustments for:

 

 

Depreciation and amortisation charges

28

6

14

 

Share based payments charge

3

-

1

 

Operating cash outflows before movement in working capital

(1,053)

(578)

(1,608)

 

(Increase)/decrease in inventories

(17)

-

(1)

 

(Increase)/decrease in trade and other receivables

(22) 

(36)

(80)

 

(Decrease)/increase in trade and other payables

(104)

116

27 

 

Cash used in operations

(1,196)

(498)

(1,660)

 

Interest received

6

11 

22 

 

Taxation received

-

-

137

 

Net cash used in operating activities

(1,190)

(487)

(1,503)

 

Cash flows from investing activities

 

 

 

Purchase of property, plant and equipment

(9)

(17)

(24)

 

Cash and bank in subsidiary at acquisition

-

-

3

 

Net cash used in investing activities

(9) 

(17)

(21)

 

 

 

Net decrease in cash and cash equivalents

(1,199)

(504)

(1,524)

 

Cash and cash equivalents at beginning of period

3,265

 4,789

4,789

 

Cash and cash equivalents at end of period

2,066

4,285

3,265

 

 

 

 

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 30 JUNE 2018

 

1) BASIS OF PREPARATION

 

The condensed interim financial statements of DeepMatter Group Plc are unaudited condensed consolidated financial statements for the six months ended 30 June 2018. These include unaudited comparatives for the six months ended 30 June 2017 together with audited comparatives for the year ended 31 December 2017.

 

The interim financial statements do not include all of the information required for full annual financial statements and do not comply with all the disclosures in IAS 34 'Interim Financial Reporting' and should be read in conjunction with the Group's annual financial statements as at 31 December 2017. Accordingly, whilst the interim statements have been prepared in accordance with IFRS, they cannot be construed as being in full compliance with IFRS.

 

The financial information for the year ended 31 December 2017 does not constitute statutory financial statements within the meaning of section 435 of the Companies Act 2006. A copy of the audited financial statements for that year has been delivered to the Registrar of Companies. The Auditors' opinion on those financial statements was unqualified, did not draw attention to any matters by way of an emphasis of matter paragraph, and it contained no statement under section 498(2) or section 498(3) of the Companies Act 2006.

 

The accounting policies adopted are consistent with those followed in the preparation of the Group's annual financial statements for the year ended 31 December 2017. As at 1 January 2018 there are no new standards or interpretations that resulted in any impact on the accounting policies, financial position or performance of the Group. The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

 

Going concern

Information on the business environment, financial position and the factors underpinning the Group's future prospects and portfolio are included in the Chairman's Statement. The Directors confirm that they are satisfied that the Group has adequate resources to continue in business for the medium term based on the current liquid resources available. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

 

2) SIGNIFICANT ACCOUNTING POLICIES

 

The accounting policies adopted are consistent with those followed in the preparation of the consolidated annual financial statements of Cronin Group Plc for the year ended 31 December 2017.

 

3) SEGMENTAL REPORTING

 

The Board is of the opinion that the business operates only one reportable operating segment, being that of the digitization of chemical space and of innovative chemical discovery.

No operating segments have been aggregated to form the above reportable operating segment. Individual projects do not meet the definition of segments, and as such the revenues and costs of individual projects are not formally separated. In addition, due to the research and development nature of the business, many projects are transitory, depending on success, and thus no meaningful data can be provided through such analysis.

 

4) LOSS PER SHARE (BASIC AND DILUTED)

 

Basic earnings or loss per share is calculated by dividing the gain or loss attributable to ordinary shareholders by the weighted average number of ordinary shares in issue during the period.

 

For diluted earnings or loss per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares.

 

 

6 months ended 30 June 2018

6 months ended 30 June 2017

Year ended 31 December 2017

 
 

 

(Unaudited)

(Unaudited)

(Audited)

 

Continuing operations

 

 

 

 

Loss attributable to equity holders of the Group (£'000)

(807)

(505)

(1,422)

 

Weighted average number of shares in issue ('000)

550,740

525,740

529,370

 

Basic and diluted loss per share (pence)

 (0.15)

 (0.10)

(0.27)

 

Total operations

 

 

 

 

Loss attributable to equity holders of the Group (£'000)

(980)

(505)

(1,464)

 

Weighted average number of dilutive shares in issue

550,740

525,740

529,370

 

Basic and diluted loss per share (pence)

(0.18)

(0.10)

(0.28)

 

 

Basic loss per share is based on the loss after tax for the period and the weighted average number of ordinary shares of £0.0001 each in issue during the period. Diluted loss per share is calculated by adjusting the average number of ordinary shares in issue during the period to assume conversion of all dilutive potential ordinary shares. The Company had a total of 23,873,334 potentially issuable dilutive ordinary shares in existence at the 30 June 2018 period end; (31 December 2017: 23,936,667; 30 June 2017: nil), comprised of 1,873,334 share options and 22,000,000 deferred consideration shares issued in relation to the acquisition of OpenIOLabs Limited. The 23,873,334 potentially issuable dilutive shares have not been included in the calculations below due to their potential issuance having an effect to reduce loss per share attributable to equity holders.

 

5) RELATED PARTY TRANSACTIONS

 

The Group has taken advantage of the exemptions contained within IAS 24 - 'Related Party Disclosures' from the requirement to disclose transactions between Group companies as these have been eliminated on consolidation.

In addition, during the period the Company paid remuneration to the Directors' in accordance with their service contracts and letters of appointment.

 

6) HALF YEAR FINANCIAL REPORT

 

A copy of the half year report, as well as the prior year annual statutory accounts, is available on the Company's website at www.deepmatter.io. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BUGDCXSGBGIU
Date   Source Headline
5th Jan 20237:00 amRNSCancellation - DEEPMATTER GROUP PLC
4th Jan 20238:00 amRNSHolding(s) in Company
29th Dec 20225:30 pmRNSDeepmatter Group
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20223:44 pmRNSResult of General Meeting
19th Dec 20222:05 pmRNSSecond Price Monitoring Extn
19th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 202211:05 amRNSSecond Price Monitoring Extn
19th Dec 202211:00 amRNSPrice Monitoring Extension
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
9th Dec 202211:05 amRNSSecond Price Monitoring Extn
9th Dec 202211:00 amRNSPrice Monitoring Extension
8th Dec 20228:46 amRNSHolding(s) in Company
2nd Dec 20227:00 amRNSPosting of Circular
1st Dec 20227:00 amRNSProposed Cancellation of Ordinary Shares
24th Nov 20227:00 amRNSCorporate Update
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading Update
26th Oct 20227:00 amRNSDeepMatter signs multi-year license agreement
26th Aug 20221:25 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHalf Year Results
28th Jun 20227:00 amRNSDeepMatter acquires AI specialist ChemIntelligence
20th Jun 20224:41 pmRNSSecond Price Monitoring Extn
20th Jun 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20222:05 pmRNSSecond Price Monitoring Extn
20th Jun 20222:00 pmRNSPrice Monitoring Extension
20th Jun 202211:05 amRNSSecond Price Monitoring Extn
20th Jun 202211:00 amRNSPrice Monitoring Extension
9th Jun 20225:26 pmRNSHolding(s) in Company
27th May 20222:30 pmRNSResult of AGM
25th May 20222:30 pmRNSIssue of Equity and TVR
23rd May 20227:00 amRNSDirectorate Change
20th May 20227:00 amRNSContract extension
11th May 20227:00 amRNSContract
27th Apr 20227:00 amRNSFinal Results
30th Mar 20224:00 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSContract
14th Feb 20227:00 amRNSDirector/PDMR Shareholding
26th Jan 20223:20 pmRNSHolding(s) in Company
26th Jan 20223:15 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSHolding(s) in Company
25th Jan 20225:45 pmRNSHolding(s) in Company
25th Jan 202212:30 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.